Jan. 23, 2024
- Qurgen announces the grand opening of its own 30,000 sqft state-of-the-art GMP facility at Qurgen’s subsidiary company: FUENT Pharmaceutics in Suzhou, China. All the clinical investigational drug SON-DP will be manufactured in our own GMP facility in the future.